Figure 1.
Patients’ organ involvement and group allocation. ∗Defined as ≥5% in BM. In addition, 11 patients had measurable microscopic disease (<5%) in BM: 7 in the skin only group; 2 in the systemic plus skin group; 2 in the systemic only group.
Patients’ organ involvement and group allocation. ∗Defined as ≥5% in BM. In addition, 11 patients had measurable microscopic disease (<5%) in BM: 7 in the skin only group; 2 in the systemic plus skin group; 2 in the systemic only group.
